Next-generation genomic profiling for oncology

We are developing a powerful liquid biopsy platform designed to detect and monitor key genomic changes from simple blood draws. Non-invasive. Precision-driven. Patient-friendly.

​

Key features in development:

​

• Ultra-sensitive detection from plasma 

• Broad genomic coverage including key driver mutations

• Minimal sample input requirements

• Rapid turnaround for clinical decision-makin

​

Built on NGS Expertise 

 

Leveraging our experience in infectious disease, reproductive health, and transplant monitoring

​

Reagents + Software Model

​

Like our other offerings, our oncology and hematology solutions will include:

​

• Treatment response monitoringReady-to-use NGS reagents optimized for liquid biopsy 

• Powerful analysis software that turns raw data into clear reports 

• Expert support for workflow integration

​

​

Genomic tools for blood disorders​Our pipeline includes genomic profiling solutions for hematological malignancies and disorders—designed to support diagnosis, monitoring, and treatment decisions.

​

Areas of focus:​

​

• Leukemia and lymphoma profiling

• Clonal hematopoiesis detection

• Treatment response monitoring

• Minimal residual disease (MRD) assessment